Please login to the form below

Not currently logged in


This page shows the latest Cyltezo news and features for those working in and with pharma, biotech and healthcare.

Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo

Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo

The FDA has approved Boehringer’s Cyltezo (adalimumab-adbm) as ‘interchangeable’ with Humira (adalimumab) in a landmark ruling. ... The approval by the US Food and Drug Administration (FDA) of Boehringer Ingelheim's Cyltezo as an interchangeable

Latest news

More from news
Approximately 5 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....